Cel-Sci
CVM
#9791
Rank
โ‚น4.46 B
Marketcap
โ‚น531.52
Share price
-1.19%
Change (1 day)
-47.51%
Change (1 year)

Cel-Sci (CVM) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น1.11 Billion

According to Cel-Sci 's latest financial reports the company's total liabilities are โ‚น1.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cel-Sci - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-09-30โ‚น1.08 B-8.47%
2024-09-30โ‚น1.18 B-17.78%
2023-09-30โ‚น1.44 B-3.64%
2022-09-30โ‚น1.49 B4.09%
2021-09-30โ‚น1.43 B-6.39%
2020-09-30โ‚น1.53 B-3.84%
2019-09-30โ‚น1.59 B-25.64%
2018-09-30โ‚น2.14 B25.07%
2017-09-30โ‚น1.71 B0.36%
2016-09-30โ‚น1.70 B-21.72%
2015-09-30โ‚น2.18 B301.88%
2014-09-30โ‚น0.54 B109.75%
2013-09-30โ‚น0.25 B-45.79%
2012-09-30โ‚น0.47 B1.94%
2011-09-30โ‚น0.46 B5.69%
2010-09-30โ‚น0.44 B-75.02%
2009-09-30โ‚น1.77 B890.79%
2008-09-30โ‚น0.17 B-25.47%
2007-09-30โ‚น0.24 B-50.39%
2006-09-30โ‚น0.48 B1016.49%
2005-09-30โ‚น43.4 M-32.12%
2004-09-30โ‚น63.94 M-17.39%
2003-09-30โ‚น77.4 M-40.95%
2002-09-30โ‚น0.13 B439.42%
2001-09-30โ‚น24.3 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
โ‚น10.404 T 930,646.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น7.379 T 659,986.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚น22.31 B 1,896.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
โ‚น3.87 B 247.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น2.987 T 267,157.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
โ‚น76.45 B 6,739.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น80.50 B 7,101.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚น0.23 B-78.67%๐Ÿ‡บ๐Ÿ‡ธ USA